Arboclofen Has Potential to Improve Social Function and Behavior in Patients with Fragile X Syndrome

Published September 9, 2012 in Science Translational Medicine

Research on animal models suggests that STX209 (arboclofen) might improve neurobehavioral function in patients affected with Fragile X Syndrome.

http://www.ncbi.nlm.nih.gov/pubmed/22993294

Filed under: , , , ,